Total Funding
91
65
Total FundingSeries C raised
Growth Score
-5 pts
Heat Score
-30 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1687
Generate Biomedicines is a biotech company that combines biology, machine learning, and biological engineering to create biomedicines.
- Michael Nohaile: Chief Scientific Officer
- Sophie de Boer: Co-Founder
About the Company
Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines. It pioneers in the field of Generative Biology, a revolutionary approach to drug development that allows them to program protein-based modalities for the first time. Generate Biomedicines has proved that its machine-learning platform can generate new
biological molecules with therapeutic value, accelerating the drug discovery process.
Women Founded
